-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Cooperation of Non-Genomic and Genomic Mechanisms of Persistence /Resistance to Pharmacological and Immune Based Therapies

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Epigenetic And Chromatin Mechanisms
Friday, December 6, 2024, 2:03 PM-2:44 PM

Constantine S Mitsiades, MD

Dana-Farber Cancer Institute, Boston, MA

Disclosures: Mitsiades: Adicet Bio: Membership on an entity's Board of Directors or advisory committees; Genentech: Consultancy; Nerviano: Consultancy; Secura Bio: Consultancy; Oncopeptides: Consultancy; EMD Serono: Research Funding; Karyopharm: Research Funding; Sanofi: Research Funding; Nurix: Research Funding; BMS: Research Funding; H3 Biomedicine/Eisai: Research Funding; Springworks: Research Funding; Abcuro: Research Funding; Novartis: Research Funding; OPNA: Research Funding.

See more of: Epigenetic And Chromatin Mechanisms
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation